BioNote, Inc. (KRX:377740)

BioNote Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	471,330	480,684	433,228	874,096	-	-
Market Cap Growth	10.95%	10.95%	-50.44%	-	-	-
Enterprise Value	69,845	83,431	16,432	174,842	-	-
Last Close Price	4650.00	4518.92	3891.98	7866.47	-	-
PE Ratio	8.58	8.70	-	2.84	-	-
PS Ratio	4.59	4.68	4.81	1.82	-	-
PB Ratio	0.29	0.29	0.28	0.55	-	-
P/TBV Ratio	0.29	0.30	0.28	0.55	-	-
P/FCF Ratio	9.93	10.13	-	4.23	-	-
P/OCF Ratio	8.14	8.30	-	3.51	-	-
EV/Sales Ratio	0.68	0.81	0.18	0.37	-	-
EV/EBITDA Ratio	1.78	4.09	-	0.58	-	-
EV/EBIT Ratio	2.24	6.83	-	0.59	-	-
EV/FCF Ratio	1.47	1.76	-	0.85	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.19	0.19	-	0.00	0.00	0.00
Debt / FCF Ratio	0.08	0.08	-	0.01	0.00	0.00
Asset Turnover	0.06	0.06	0.05	0.30	0.53	1.28
Inventory Turnover	1.86	1.86	1.86	1.94	1.87	1.71
Quick Ratio	18.20	18.20	39.35	14.94	4.84	2.80
Current Ratio	19.69	19.69	42.26	16.66	5.42	3.12
Return on Equity (ROE)	3.46%	3.46%	-1.30%	21.43%	70.80%	141.00%
Return on Assets (ROA)	0.46%	0.46%	-1.76%	11.38%	25.01%	70.87%
Return on Capital (ROIC)	0.48%	0.48%	-1.86%	12.85%	30.64%	91.58%
Return on Capital Employed (ROCE)	0.70%	0.70%	-	17.30%	34.20%	83.30%
Earnings Yield	11.72%	11.50%	-4.73%	35.21%	-	-
FCF Yield	10.07%	9.87%	-1.88%	23.66%	-	-
Payout Ratio	36.94%	36.94%	-	16.23%	7.38%	-
Buyback Yield / Dilution	0.08%	0.08%	-8.16%	-0.64%	-0.14%	-11.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.